{"id":27903,"date":"2025-11-18T16:11:57","date_gmt":"2025-11-18T23:11:57","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27903"},"modified":"2025-11-18T16:12:01","modified_gmt":"2025-11-18T23:12:01","slug":"ivig-for-hematophagocytic-lymphohistiocytosis-hlh","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/","title":{"rendered":"IVIG \u0111i\u1ec1u tr\u1ecb b\u1ec7nh u m\u00f4 b\u00e0o lympho th\u1ef1c b\u00e0o (HLH)"},"content":{"rendered":"\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/hemophagocytic-lymphohistiocytosis-hlh\/\">Hematophagocytic lymphohistiocytosis<\/a> (HLH) is a rare, life-threatening condition where the immune system becomes dangerously overactive, attacking its own tissues and organs. Without early and proper treatment, HLH can lead to severe inflammation, multi-organ failure, and even death. Although HLH primarily affects infants and young children, adults can also develop this condition [<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557776\/\">2<\/a>].<\/p>\n\n\n\n<div  id=\"call-to-action-5da5d67c570e0781400bc5404afb51c8\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>To improve survival in HLH, proper and early treatment is key. In recent years, among the available treatment options, <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig\/\">intravenous immunoglobulin<\/a> (IVIG) therapy has delivered promising results. In this article, we will discuss everything you need to know about IVIG for hematophagocytic lymphohistiocytosis (HLH).<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#Hematophagocytic_Lymphohistiocytosis_HLH_Overview\" >Hematophagocytic Lymphohistiocytosis (HLH): Overview<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#Signs_and_Symptoms_of_HLH\" >Signs and Symptoms of HLH<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#Standard_Treatment_for_HLH\" >Standard Treatment for HLH<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#How_Does_IVIG_Help_Patients_With_Hematophagocytic_Lymphohistiocytosis_HLH\" >How Does IVIG Help Patients With Hematophagocytic Lymphohistiocytosis (HLH)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#Effectiveness_of_IVIG_in_Hematophagocytic_Lymphohistiocytosis_HLH_What_Studies_Say\" >Effectiveness of IVIG in Hematophagocytic Lymphohistiocytosis (HLH): What Studies Say<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hematophagocytic_Lymphohistiocytosis_HLH_Overview\"><\/span><strong>Hematophagocytic Lymphohistiocytosis (HLH): Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Normally, when a foreign pathogen like a virus or bacteria enters the body, the immune system launches a controlled response to eliminate the infection. When the foreign pathogen is destroyed, the immune response gradually fades. However, in hematophagocytic lymphohistiocytosis (HLH), the immune system becomes overactive. Various immune cells, such as T-lymphocytes and macrophages, start attacking the blood cells, tissues, and organs. This can cause multiple organ failure and lead to death [<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557776\/\">2<\/a>][<a href=\"https:\/\/en.wikipedia.org\/wiki\/Hemophagocytic_lymphohistiocytosis#Causes\">3<\/a>].<\/p>\n\n\n\n<p>There are two main types of HLH. They are [<a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/hemophagocytic-lymphohistiocystosis\">1<\/a>]:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Primary (Familial) HLH:<\/strong> An inherited disease caused by genetic mutations. It usually appears in infancy or early childhood. Primary HLH accounts for about 25% of all HLH cases.<\/li>\n<\/ol>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong>Secondary (Acquired) HLH:<\/strong> Secondary HLH is triggered by various causes, including infections (such as Epstein-Barr virus), autoimmune diseases (like lupus), cancers, or certain medications.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Signs_and_Symptoms_of_HLH\"><\/span><strong>Signs and Symptoms of HLH<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The symptoms of HLH develop rapidly, and the severity varies from person to person. Some common symptoms of HLH include [<a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/hemophagocytic-lymphohistiocystosis\">1<\/a>][<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557776\/\">2<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>High and persistent fever<\/li>\n\n\n\n<li>Enlarged liver and spleen<\/li>\n\n\n\n<li>Low blood cell counts (anemia, low platelets, low white blood cells)<\/li>\n\n\n\n<li>Skin rash<\/li>\n\n\n\n<li>Enlarged lymph nodes<\/li>\n\n\n\n<li>Elevated iron level in blood<\/li>\n\n\n\n<li>Jaundice (yellowing of the skin or eyes)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Standard_Treatment_for_HLH\"><\/span><strong>Standard Treatment for HLH<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient.jpg\" alt=\"Doctor discusing HLH with a patient at a hospital\" class=\"wp-image-27905\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/doctor-patient-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>The main goal of HLH treatment is to suppress the overactive immune system and prevent further organ damage. Standard treatment depends on whether HLH is primary or secondary and may include [<a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/hemophagocytic-lymphohistiocystosis\">1<\/a>][<a href=\"https:\/\/en.wikipedia.org\/wiki\/Hemophagocytic_lymphohistiocytosis#Causes\">3<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Corticosteroids (e.g., dexamethasone):<\/strong> These drugs reduce inflammation and calm the overactive immune system.<\/li>\n\n\n\n<li><strong>Etoposide:<\/strong> A chemotherapy drug used to destroy overactive immune cells.<\/li>\n\n\n\n<li><strong>Hematopoietic Stem Cell Transplant:<\/strong> This is the only possible cure for primary HLH.<\/li>\n\n\n\n<li><strong>Supportive care:<\/strong> Includes antibiotics, antivirals, blood transfusions, and management of organ failure.<\/li>\n\n\n\n<li><strong>Intravenous Immunoglobulin (IVIG):<\/strong> IVIG, when combined with other medications such as corticosteroids, is an effective treatment for HLH. It can help you get better by reducing the inflammation and regulating the immune response.<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-a3029b44712b2050fc405d2bc5698fe1\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAbout Copay Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Help_Patients_With_Hematophagocytic_Lymphohistiocytosis_HLH\"><\/span><strong>How Does IVIG Help Patients With Hematophagocytic Lymphohistiocytosis (HLH)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Intravenous Immunoglobulin (IVIG) is a highly purified medical product made from the plasma of thousands of healthy blood donors. It contains antibodies that help balance and regulate the immune system in various autoimmune, inflammatory, or immunodeficiency conditions.&nbsp;<\/p>\n\n\n\n<p>In hematophagocytic lymphohistiocytosis (HLH), the immune system becomes hyperactive and attacks its own blood cells, tissues, and organs. In this condition, IVIG can help by:<\/p>\n\n\n\n<p><strong>Modulating the Immune Response:<\/strong> IVIG can help calm an overactive immune system by suppressing immune cells like T-cells and macrophages that cause inflammation and tissue damage [<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/\">4<\/a>][<a href=\"https:\/\/doi.org\/10.3389\/fimmu.2015.00469\">5<\/a>]. By regulating these cells, IVIG helps prevent further damage to the body.<\/p>\n\n\n\n<p><strong>Neutralizing Cytokines and Autoantibodies:<\/strong> In HLH, the immune system releases excessive cytokines (molecules that cause widespread inflammation) and produces autoantibodies that attack the body\u2019s own cells. This uncontrolled immune activity leads to severe tissue damage and organ failure. IVIG can reduce inflammation and protect the body from further harm by neutralizing these harmful cytokines and autoantibodies [<a href=\"https:\/\/doi.org\/10.3389\/fimmu.2015.00469\">6<\/a>].<\/p>\n\n\n\n<p><strong>Providing Passive Immunity:<\/strong> In cases where HLH is triggered by an infection, IVIG offers ready-made antibodies that help the body fight off the infection.&nbsp;<\/p>\n\n\n\n<p><strong>Protecting Organs:<\/strong> By reducing the inflammatory response, IVIG helps protect vital organs from further damage.&nbsp;<\/p>\n\n\n\n<p>Overall, IVIG does not cure HLH on its own. But it serves an essential supportive role, especially in secondary HLH caused by infections or autoimmune diseases. When used early and alongside other standard treatments, IVIG can help stabilize patients, control inflammation, and improve overall outcomes [<a href=\"https:\/\/doi.org\/10.5005\/jp-journals-11006-0133\">7<\/a>].<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Effectiveness_of_IVIG_in_Hematophagocytic_Lymphohistiocytosis_HLH_What_Studies_Say\"><\/span><strong>Effectiveness of IVIG in Hematophagocytic Lymphohistiocytosis (HLH): What Studies Say<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Studies suggest that the effectiveness of Intravenous Immunoglobulin (IVIG) in treating Hemophagocytic Lymphohistiocytosis (HLH) largely depends on the type of HLH and the timing of treatment. While IVIG is not a cure for HLH, it is a valuable tool, particularly in secondary HLH (sHLH), which develops as a result of infections, autoimmune diseases, or cancers.<\/p>\n\n\n\n<p>Over the past decade, research has increasingly supported IVIG combined with corticosteroids as an initial treatment for secondary HLH (sHLH). This approach is especially valuable in patients for whom doctors want to avoid the serious side effects associated with etoposide, a chemotherapy drug commonly used in standard HLH treatment regimens.&nbsp;<\/p>\n\n\n\n<p>For example, a 2014 study involving 40 children with HLH found that the combination of IVIG and Dexamethasone was a more preferable initial regimen than etoposide-based treatment. This is because the IVIG regimen can avoid the long-term risks of secondary cancers linked to etoposide use [<a href=\"https:\/\/doi.org\/10.1007\/s12098-014-1461-0\">8<\/a>].<\/p>\n\n\n\n<p>A more recent 2024 study highlighted the critical importance of early administration. The study observed that secondary HLH (sHLH) patients with sepsis who received IVIG and Dexamethasone early in their disease course showed significant clinical and laboratory improvements. On the other hand, patients who received IVIG late in their treatment had poorer outcomes, often resulting in death. This study suggests that there is a narrow window for maximum efficacy [<a href=\"https:\/\/doi.org\/10.5005\/jp-journals-11006-0133\">7<\/a>].<\/p>\n\n\n\n<p>Similarly, the UK\u2019s National Health Service (NHS) includes IVIG as a recognized treatment option for secondary HLH [<a href=\"https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2025\/06\/HLH-Guide-final-version-v1.3-June-2025.pdf\">10<\/a>]. In one reported case study, two secondary HLH patients were treated with IVIG for five consecutive days [<a href=\"https:\/\/jag.journalagent.com\/tjh\/pdfs\/TJH_20_2_95_99.pdf\">9<\/a>]. Both of them recovered fully from their illness.<\/p>\n\n\n\n<p>However, IVIG\u2019s effectiveness appears to diminish in other HLH subtypes. A study of 46 adult HLH patients reported better long-term survival in infection-associated HLH but very poor long-term survival in malignancy-associated HLH [<a href=\"https:\/\/acrabstracts.org\/abstract\/intravenous-immunoglobulin-therapy-for-secondary-hemophagocytic-lymphohistiocytosis-a-retrospective-study-of-46-patients\/\">11<\/a>]. Again, in cases of primary HLH, etoposide-based chemotherapy remains the standard of care.&nbsp;<\/p>\n\n\n\n<p>In summary, IVIG plays a valuable supportive role in managing infection-triggered or autoimmune-related secondary HLH when given early in the disease course. However, in primary HLH or cancer-related secondary HLH, the benefits of IVIG are limited. Therefore, we need more large-scale clinical trials to better define IVIG\u2019s role, optimal dosing, and combination strategies in different subtypes of HLH.<\/p>\n\n\n\n<div  id=\"call-to-action-e84565494eaaa6ec3c971bdb35691fbf\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Prior Authorization\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Here are some of the most frequently asked questions about IVIG for hematophagocytic lymphohistiocytosis (HLH):<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>1. Is IVIG FDA-approved for treating HLH?<\/strong><\/h4>\n\n\n\n<p><strong>No.<\/strong> IVIG is not FDA-approved specifically for the treatment of HLH. However, IVIG is used \u201coff-label\u201d for treating HLH based on clinical judgment. Studies showed that IVIG is effective in treating HLH, particularly infection-associated or immune-related HLH.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>2. Can IVIG cure HLH on its own?<\/strong><\/h4>\n\n\n\n<p><strong>No.<\/strong> IVIG alone cannot cure HLH. It can help stabilize the immune system and reduce inflammation. But IVIG usually needs to be combined with corticosteroids (e.g., dexamethasone) or other therapies.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>3. How long does it take for IVIG to work in HLH?<\/strong><\/h4>\n\n\n\n<p>Some patients see clinical improvements within 24-72 hours after starting IVIG treatment. However, the results vary depending on the severity, cause, and timing of treatment.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>4. What is the typical dose of IVIG for HLH?<\/strong><\/h4>\n\n\n\n<p>The typical dose of IVIG ranges from 1 to 2 grams per kilogram of your body weight. It can be given as a single infusion or divided into smaller doses spread over 2 \u2013 5 days [<a href=\"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0309-6\/tables\/3\">12<\/a>][<a href=\"https:\/\/www.criteria.blood.gov.au\/MedicalCondition\/View\/2573\">13<\/a>][<a href=\"https:\/\/doi.org\/10.12998\/wjcc.v7.i21.3394\">14<\/a>]. The exact dosing schedule depends on several factors, including the severity of your condition, response to treatment, and how well you tolerate the infusion. Your doctor will determine the most suitable dose and duration for you to achieve the best results.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>H\u1ed9i ch\u1ee9ng t\u0103ng sinh t\u1ebf b\u00e0o lympho th\u1ef1c b\u00e0o (HLH) l\u00e0 m\u1ed9t b\u1ec7nh hi\u1ebfm g\u1eb7p, \u0111e d\u1ecda t\u00ednh m\u1ea1ng, trong \u0111\u00f3 h\u1ec7 th\u1ed1ng mi\u1ec5n d\u1ecbch tr\u1edf n\u00ean ho\u1ea1t \u0111\u1ed9ng qu\u00e1 m\u1ee9c nguy hi\u1ec3m, t\u1ea5n c\u00f4ng c\u00e1c m\u00f4 v\u00e0 c\u01a1 quan c\u1ee7a ch\u00ednh c\u01a1 th\u1ec3. N\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb s\u1edbm v\u00e0 \u0111\u00fang c\u00e1ch, HLH c\u00f3 th\u1ec3 d\u1eabn \u0111\u1ebfn vi\u00eam nhi\u1ec5m nghi\u00eam tr\u1ecdng, suy \u0111a c\u01a1 quan v\u00e0 th\u1eadm ch\u00ed t\u1eed vong.<\/p>","protected":false},"author":13,"featured_media":27904,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[17],"class_list":["post-27903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Hematophagocytic Lymphohistiocytosis (HLH) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Understand how IVIG treats HLH, its benefits, effectiveness, dosing, and role in managing secondary hemophagocytic lymphohistiocytosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Hematophagocytic Lymphohistiocytosis (HLH) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Understand how IVIG treats HLH, its benefits, effectiveness, dosing, and role in managing secondary hemophagocytic lymphohistiocytosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T23:11:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T23:12:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"IVIG for Hematophagocytic Lymphohistiocytosis (HLH)\",\"datePublished\":\"2025-11-18T23:11:57+00:00\",\"dateModified\":\"2025-11-18T23:12:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/\"},\"wordCount\":1256,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/ivig-for-hlh.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/\",\"name\":\"IVIG for Hematophagocytic Lymphohistiocytosis (HLH) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/ivig-for-hlh.jpg\",\"datePublished\":\"2025-11-18T23:11:57+00:00\",\"dateModified\":\"2025-11-18T23:12:01+00:00\",\"description\":\"Understand how IVIG treats HLH, its benefits, effectiveness, dosing, and role in managing secondary hemophagocytic lymphohistiocytosis.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/ivig-for-hlh.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/ivig-for-hlh.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Nurse overseeing a patient at home receiving IVIG for hematophagocytic lymphohistiocytosis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Hematophagocytic Lymphohistiocytosis (HLH)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG \u0111i\u1ec1u tr\u1ecb b\u1ec7nh u m\u00f4 b\u00e0o lympho th\u1ef1c b\u00e0o (HLH) - AmeriPharma\u00ae Ch\u0103m s\u00f3c chuy\u00ean khoa","description":"T\u00ecm hi\u1ec3u c\u00e1ch IVIG \u0111i\u1ec1u tr\u1ecb HLH, l\u1ee3i \u00edch, hi\u1ec7u qu\u1ea3, li\u1ec1u l\u01b0\u1ee3ng v\u00e0 vai tr\u00f2 c\u1ee7a n\u00f3 trong vi\u1ec7c qu\u1ea3n l\u00fd b\u1ec7nh u m\u00f4 b\u00e0o th\u1ef1c b\u00e0o th\u1ee9 ph\u00e1t.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/","og_locale":"vi_VN","og_type":"article","og_title":"IVIG for Hematophagocytic Lymphohistiocytosis (HLH) - AmeriPharma\u00ae Specialty Care","og_description":"Understand how IVIG treats HLH, its benefits, effectiveness, dosing, and role in managing secondary hemophagocytic lymphohistiocytosis.","og_url":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-11-18T23:11:57+00:00","article_modified_time":"2025-11-18T23:12:01+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"6 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"IVIG for Hematophagocytic Lymphohistiocytosis (HLH)","datePublished":"2025-11-18T23:11:57+00:00","dateModified":"2025-11-18T23:12:01+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/"},"wordCount":1256,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["IVIG"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/","name":"IVIG \u0111i\u1ec1u tr\u1ecb b\u1ec7nh u m\u00f4 b\u00e0o lympho th\u1ef1c b\u00e0o (HLH) - AmeriPharma\u00ae Ch\u0103m s\u00f3c chuy\u00ean khoa","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg","datePublished":"2025-11-18T23:11:57+00:00","dateModified":"2025-11-18T23:12:01+00:00","description":"T\u00ecm hi\u1ec3u c\u00e1ch IVIG \u0111i\u1ec1u tr\u1ecb HLH, l\u1ee3i \u00edch, hi\u1ec7u qu\u1ea3, li\u1ec1u l\u01b0\u1ee3ng v\u00e0 vai tr\u00f2 c\u1ee7a n\u00f3 trong vi\u1ec7c qu\u1ea3n l\u00fd b\u1ec7nh u m\u00f4 b\u00e0o th\u1ef1c b\u00e0o th\u1ee9 ph\u00e1t.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg","width":1280,"height":853,"caption":"Nurse overseeing a patient at home receiving IVIG for hematophagocytic lymphohistiocytosis"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-hematophagocytic-lymphohistiocytosis-hlh\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"IVIG for Hematophagocytic Lymphohistiocytosis (HLH)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website","url":"https:\/\/ameripharmaspecialty.com\/vi\/","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","description":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t c\u1ee7a AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Ti\u1ebfn s\u0129 Saba Rassouli, Ti\u1ebfn s\u0129 D\u01b0\u1ee3c","image":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"Ti\u1ebfn s\u0129 Saba Rassouli, Ti\u1ebfn s\u0129 D\u01b0\u1ee3c sinh ra v\u00e0 l\u1edbn l\u00ean t\u1ea1i Iran. C\u00f4 \u0111\u00e3 nh\u1eadn b\u1eb1ng d\u01b0\u1ee3c s\u0129 c\u1ee7a \u0110\u1ea1i h\u1ecdc Marshall B. Ketchum v\u00e0o n\u0103m 2022, n\u01a1i c\u00f4 t\u1ed1t nghi\u1ec7p lo\u1ea1i xu\u1ea5t s\u1eafc. Ph\u1ea7n b\u1ed5 \u00edch nh\u1ea5t trong c\u00f4ng vi\u1ec7c c\u1ee7a c\u00f4 l\u00e0 c\u00f3 c\u01a1 h\u1ed9i ch\u0103m s\u00f3c t\u1eebng b\u1ec7nh nh\u00e2n nh\u01b0 th\u1ec3 h\u1ecd l\u00e0 gia \u0111\u00ecnh v\u00e0 l\u1eafng nghe h\u1ecd n\u00f3i v\u1ec1 m\u1ee9c \u0111\u1ed9 h\u1ea1nh ph\u00fac v\u00e0 h\u00e0i l\u00f2ng c\u1ee7a h\u1ecd v\u1edbi c\u00e1c d\u1ecbch v\u1ee5 do AmeriPharma cung c\u1ea5p. Trong th\u1eddi gian r\u1ea3nh r\u1ed7i, c\u00f4 th\u00edch \u0111i d\u1ea1o, \u0111\u1ecdc s\u00e1ch v\u00e0 th\u1eed c\u00e1c nh\u00e0 h\u00e0ng v\u00e0 m\u00f3n \u0103n kh\u00e1c nhau.","url":"https:\/\/ameripharmaspecialty.com\/vi\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Hematophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition where the immune system becomes dangerously overactive, attacking its own tissues and organs. Without early and proper treatment, HLH can lead to severe inflammation, multi-organ failure, and even death.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/11\/ivig-for-hlh.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/vi\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Hematophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition where the immune system becomes dangerously overactive, attacking its own tissues and organs. Without early and proper treatment, HLH can lead to severe inflammation, multi-organ failure, and even death.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/27903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/comments?post=27903"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/27903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media\/27904"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media?parent=27903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/categories?post=27903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/tags?post=27903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}